![Christopher Twitty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Twitty
Hoofd Techniek/Wetenschap/O&O bij
SKYE BIOSCIENCE, INC.
Vermogen: 46 145 $ op 31-07-2026
Profiel
Christopher G.
Twitty is Chief Scientific Officer at Skye Bioscience, Inc. since 2022.
Formerly, Dr. Twitty was Independent Director at Larkspur Health Acquisition Corp., Chief Scientific Officer, Head-R&D at OncoSec Medical, Inc. from 2017 to 2021, and Chief Scientific Officer at Onchilles Pharma, Inc. from 2021 to 2022.
Education includes a doctorate from Oregon Health & Science University and an undergraduate degree from San Diego State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 81.242 ( 0,23% ) | 46 145 $ | 31-07-2026 |
Actieve functies van Christopher Twitty
| Bedrijven | Functie | Begin |
|---|---|---|
| SKYE BIOSCIENCE, INC. | Hoofd Techniek/Wetenschap/O&O | 13-12-2022 |
Eerdere bekende functies van Christopher Twitty
| Bedrijven | Functie | Einde |
|---|---|---|
Onchilles Pharma, Inc.
 Onchilles Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company | Hoofd Techniek/Wetenschap/O&O | 01-12-2022 |
| ONCOSEC MEDICAL INCORPORATED | Hoofd Techniek/Wetenschap/O&O | 20-10-2021 |
| LARR HEALPAR | Directeur/Bestuurslid | - |
Opleiding van Christopher Twitty
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
41
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
OncoSec Medical, Inc.
 OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oregon Health & Science University
 Oregon Health & Science University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skye Bioscience, Inc.
 Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Onchilles Pharma, Inc.
Onchilles Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company | Commercial Services |
Larkspur Health Acquisition Corp.
 Larkspur Health Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
